Related Experiment Video
Updated: Jan 13, 2026

10:33
An Enrichment Method for Small Extracellular Vesicles Derived from Liver Cancer Tissue
Published on: February 3, 2023
1.7K
Extracellular vesicles in colorectal cancer
Young Il Kim1,2,3, Chungyeop Lee1, Hakho Lee2,3
1Division of Colon and Rectal Surgery, Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Annals of Coloproctology
|October 29, 2025
Summary
Extracellular vesicles (EVs) in liquid biopsies show promise for colorectal cancer (CRC) detection and monitoring. Research highlights their role in CRC progression and potential as biomarkers for diagnosis and treatment.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Colorectal cancer (CRC) presents significant global health challenges, particularly in early detection and recurrence monitoring.
- Current screening methods like colonoscopy and fecal tests have limitations, prompting research into less invasive alternatives.
- Extracellular vesicles (EVs) in liquid biopsies are emerging as promising biomarkers due to their molecular cargo reflecting the tumor's status.
Purpose of the Study:
- To review the role of EVs in colorectal cancer initiation and progression.
- To summarize advancements in EV isolation techniques for clinical application.
- To identify potential EV-derived biomarkers for CRC diagnosis, prognosis, and treatment monitoring.
Main Methods:
- Literature review of current research on extracellular vesicles in colorectal cancer.
- Analysis of EV cargo (nucleic acids, proteins) as potential biomarkers.
- Evaluation of EV isolation and detection methodologies.
Main Results:
- EVs play a crucial role in colorectal cancer development and progression.
- Minimally invasive liquid biopsy using EVs offers a viable alternative to traditional screening.
- Specific EV-derived molecules show potential as diagnostic and prognostic biomarkers for CRC.
Conclusions:
- Extracellular vesicles hold significant potential as biomarkers for colorectal cancer management.
- Further research and clinical validation are needed to translate EV-based approaches into routine practice.
- EVs may offer novel therapeutic strategies and improved monitoring for colorectal cancer patients.
Related Concept Videos
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Cancer Cell Migration through Invadopodia
3.2K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K

